Exploring the medication pattern and mechanism of action of traditional Chinese medicine in treating polycystic ovary syndrome with kidney deficiency and blood stasis based on data mining and network pharmacology

Background:Using network pharmacology to explore the potential molecular mechanism of traditional Chinese medicine in treating polycystic ovary syndrome(PCOS)with kidney deficiency and blood stasis syndrome.Method:Collect the related literature materials of PCOS with kidney deficiency and blood stasis syndrome treated by traditional Chinese medicine in four databases in recent ten years,extract the information of prescriptions and complete the frequency analysis.Traditional Chinese Medicine Systems Pharmacology Database was used to screen out the effective components.Use Online Mendelian Inheritance in Man and other databases to screen PCOS disease targets.The intersection targets obtained by clustering prescription and PCOS disease targets were submitted to STRING database for protein-protein interaction network analysis,and Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes pathways were analysed by Metascape.Result:There are 155 kinds of traditional Chinese medicines used in the literature.The most commonly utilized ones are Cuscutae Semen,Angelicae Sinensis Radix,and Rehmanniae Radix Praeparata.The results of the cluster analysis indicated that the plants most commonly found throughout the prescription were Leonuri Herba,Lycopi Herba,Dipsaci Radix,etc.GO results show that biological processes include cell reaction to organic nitrogen compounds and cell reaction to nitrogen compounds.The functional display of GO molecule includes cytokine receptor binding,signal receptor regulator activity and so on.Kyoto Encyclopedia of Genes and Genomes results show that the possible mechanisms of action are cancer pathway,an endocrine resistance signal pathway.Conclusion:Through data mining,the cluster prescription for PCOS with kidney deficiency and blood stasis syndrome is Leonuri Herba,Lycopi Herba,Dipsaci Radix,etc.The network pharmacology research of cluster prescription shows that the main drug components for treating PCOS with kidney deficiency and blood stasis syndrome are quercetin,kaempferol,luteolin,tanshinone IIA,etc.,which act on PTGS2,NCOA2,and other targets,and treat PCOS with kidney deficiency and blood stasis syndrome through cancer and endocrine resistance.

Clinical Nursing Intervention of Moxibustion on Abdominal Distension Symptoms in Heart Failure (Heart and Kidney Yang Deficiency and Blood Stasis Blocking Collaterals Syndrome)

Objective:To investigate the clinical nursing intervention effect of moxibustion on abdominal distension symptoms in heart failure(heart and kidney yang deficiency and blood stasis blocking collaterals syndrome).Methods:62 patients with heart failure(heart and kidney yang deficiency and blood stasis blocking collaterals syndrome)admitted to our hospital from February 2023 to February 2024 were selected and divided into the observation group(n=31)and the control group(n=31)by using the random numerical table method.The control group adopted conventional nursing interventions,and the observation group received the nursing program of the control group with the addition of moxibustion nursing interventions.The nursing effectiveness,quality of life scores,and nursing satisfaction were compared between the two groups.Results:The nursing effectiveness of the observation group was significantly higher than the control group(P<0.05);the quality of life score of the observation group was significantly higher than the control group(P<0.05);the nursing satisfaction of the observation group was significantly higher than that of the control group(P<0.05).Conclusion:The use of moxibustion nursing intervention in patients with heart failure(heart and kidney yang deficiency and blood stasis blocking collaterals syndrome)can effectively relieve the symptoms of abdominal distension,improve patients'quality of life,and increase nursing satisfaction,which has promotion and application values.

Clinical observation on efficacy of compound of warming yang, descending turbidity and dredging collaterals in the treatment of diabetic kidney disease with Yin-Yang deficiency and blood stasis syndrome

Objective:To observe the clinical efficacy of compound of owarming yang,descending turbidity and dredging collaterals in the treatment of diabetic kidney disease with yin-yang deficiency and blood stasis syndrome.Methods:Seventy-six patients of diabetic kidney disease with yin-yang deficiency and blood stasis syndrome were randomly divided into observation group and control group,thirty-eight cases in each group.The control group was given conventional western medicine treatment,while the observation group took compound of owarming yang,descending turbidity and dredging collaterals orally on the basis of conventional western medicine treatment.The course of treatment covered for one month.Before and after treatment,we observed the scores of traditional Chinese medicine symptoms,indicators of renal function[serum creatinine(Scr),blood urea nitrogen(BUN),microalbuminuria(MALB)],indicators of glucose metabolism[fasting plasma glucose(FPG),2-hour postprandial blood glucose(2hPG),glycosylated hemoglobin(HbAlc)],indicators of hemorheology[plasma viscosity(PV),platelet aggregation rate(PAR),fibrinogen(FIB)],Cystatin-C(Cys-C),C-reactive protein(CRP)in the two groups.Results:After treatment,the clinical effect of the observation group was significantly better than the control group(P<0.05).The scores of traditional Chinese medicine symptoms,indicators of renal function(Scr、BUN、UAER),indicators of glucose metabolism(FPG、2hPG、HbAlc),indicators of hemorheology(PV、PAR、FIB),Cys-C and CRP in the two groups were decreased significantly compared with those before treatment(P<0.05),and the decrease in the observation group was superior to that in the control group(P<0.05).Conclusion:Compound of warming yang,descending turbidity and dredging collaterals has remarkable efficacy in treating of diabetic kidney disease patients with yin-yang deficiency and blood stasis syndrome by alleviating clinical symptoms,glucose metabolism,renal function and microcirculatory disturbance,and the mechanism related to alleviation of microinflammation.

基于气络学说运用芪归通络口服液联合艾灸治疗气虚血瘀型慢性疲劳综合征的临床观察

【目的】观察基于气络学说,运用芪归通络口服液(广东省第二中医院院内制剂,由黄芪、当归、三七、赤芍、牛膝、鸡血藤、丹参、地龙等中药组成)联合艾灸治疗气虚血瘀型慢性疲劳综合征(chronic fatigue syndrome,CFS)的临床疗效。【方法】采用回顾性研究方法,根据治疗方法的不同将60例气虚血瘀型CFS患者分为观察组和对照组,每组各30例。对照组给予艾条温和灸神阙穴治疗,观察组在对照组的基础上联合芪归通络口服液治疗,疗程为4周。观察2组患者治疗前后中医证候积分、疲劳量表-14(FS-14)评分、血清免疫球蛋白IgA、IgM、IgG含量及皮质醇(COR)水平的变化情况,并评价2组患者的临床疗效和安全性。【结果】(1)疗效方面,治疗4周后,观察组的总有效率为96.67%(29/30),对照组为80.00%(24/30),组间比较,观察组的临床疗效明显优于对照组(P<0.05)。(2)量表评分方面,治疗后,2组患者的中医证候积分、FS-14评分均较治疗前明显降低(P<0.01),且观察组对中医证候积分、FS-14评分的降低作用均明显优于对照组(P<0.01)。(3)实验室指标方面,治疗后,2组患者血清IgA、IgG水平以及观察组血清IgM、COR水平均较治疗前明显升高(P<0.01),且观察组对血清IgA、IgM、IgG及COR水平的升高作用均明显优于对照组(P<0.05或P<0.01)。(4)安全性方面,治疗过程中,2组患者均未发生明显不良反应。【结论】基于中医气络学说,以正虚络阻为CFS核心病机,运用补虚通络法,采用芪归通络口服液联合艾灸治疗气虚血瘀型CFS患者疗效确切,能明显缓解患者的临床症状,提高患者的免疫力水平,调节患者的神经-内分泌-免疫(NEI)网络。

基于“玄府气液”理论治疗慢性难愈性溃疡

慢性难愈性溃疡是“虚”“瘀”两种致病因素相互交织、相互作用的结果,“虚”“瘀”贯穿疾病发展的始终。而“玄府开阖失司,气液代谢失调”是本病迁延难治的病机关键。刘丽芳教授综合运用煨脓生肌、阳和通玄、托里消毒诸法开玄府、调气液,令玄府开阖有司,气液代谢调和,临床疗效满意,附验案一则加以阐明。

基于“络病学说”探析视网膜动脉阻塞的诊疗

视网膜动脉阻塞(RAO)是眼科危急重症,主要表现为无痛性视力下降,发病率较高,预后不佳。目前,西医治疗RAO仍无法获得满意的疗效,中医治疗RAO具有独特的优势,而络病理论的发展又为该病的诊疗提供了新的视角。本文基于络脉与视网膜微小动脉解剖与功能的一致性,试将络病学说应用于RAO的诊疗,提出本病的发病基础为络虚不荣,病机关键为邪瘀阻络。在通络原则指导下,治疗上可应用辛味、虫类、藤类药祛邪通络,补益药通补络虚,辅以穴位针刺,为RAO的诊疗提供新思路。

基于“伏邪理论”探讨中医药抗溃疡性结肠炎复发的诊疗策略

溃疡性结肠炎(ulcerative colitis,UC)是一种病因尚未阐明的好发于直肠和结肠的慢性炎症性疾病,目前尚无确切有效的治疗方法,其具有周期性、反复发作等发病特点,此与中医学“伏邪理论”认识趋同。该文试从中医“伏邪理论”入手,回顾相关典籍,结合本团队的临床经验,对UC的中医发病机制进行重新探讨。认为湿热、瘀血是伏邪的重要组成部分,脾虚是伏邪产生的基础,而伏邪所致的肠络受损是UC发生的病理基础,因此临证遣方用药时谨遵扶正祛邪、透邪外出的治疗总纲,提出清热利湿是祛除伏邪的首要治则,健脾温中为重要保障,理气活血是主要方式,而顾护胃气则需贯穿治疗始终,由此创立的清肠温中方具有明显的临床疗效,并能有效防治UC的复发。该文分别从“伏邪理论”源流、伏邪在UC发病中的特点及在诊疗中的应用等探讨了中医药抗UC复发的诊疗策略,并附本团队防治UC复发的经验,以期对该病的临床治疗有所裨益。

从气虚血瘀探讨铁死亡与椎动脉型颈椎病的关系

从气虚血瘀探讨铁死亡与椎动脉型颈椎病(CSA)的关系。椎动脉遭受刺激、压迫后的缺血、缺氧状态是CSA发生的病理基础。中医认为CSA的关键病机是气虚血瘀,气虚推动无力,瘀血内停,血液流变学指标改变,病理产物积聚,容易触发血管内皮细胞铁死亡,加重病情进展。从气虚血瘀病机与铁死亡理论探讨CSA的中医药防治,为CSA的临床诊治提供新思路。

吴门医派络病理论干预治疗PCI术后气虚血瘀证的临床治疗效果

目的观察吴门医派络病理论干预治疗PCI术后气虚血瘀证的疗效。方法采用随机对照研究方法,共纳入南京中医药大学附属苏州市中医医院2018年1月—2022年1月就诊的PCI术后气虚血瘀证患者70例,实际纳入对照组30例,治疗组32例,脱落8例,脱落率为11.43%。对照组给予西医常规治疗,治疗组给予加味生脉散配伍活血化瘀药干预治疗结合西医常规治疗。观察治疗前和治疗3个月后中医证候改善率、生活质量评估情况、超敏C反应蛋白、血清N末端B型利钠肽原(N-terminal pro-B-type natriuretic peptide,NT-proBNP)水平的变化差异情况。结果治疗3个月后,治疗组中医症候改善率为84.38%,对照组为53.33%,治疗组高于对照组(P<0.05)。治疗3个月后,治疗组的活动受限程度、心绞痛发作频率、心绞痛稳定状态、疾病认识程度、治疗满意程度等均优于对照组,差异有统计学意义(P<0.05)。治疗后30 d治疗组hs-CRP[(5.17±4.13)ng/L]及NT-proBNP[(860.70±329.60)pg/mL]均低于对照组[(13.60±5.65)ng/L,(1402.40±401.66)pg/mL],差异有统计学意义(P<0.05)。结论吴门医派络病理论指导下加味生脉散配伍活血化瘀结合西医常规治疗,能更有效改善PCI术后气虚血虚证患者的生活质量,降低术后心血管不良事件发生。

由“虚瘀”理论探讨耆鹿逐痹胶囊防治肾虚血瘀型骨质疏松的作用

骨质疏松症是一种以骨量下降为主要特点的骨代谢性疾病,归属中医“骨痿”范畴,其发病率正逐年上升。常兼见疼痛症状且易引发病理性骨折,让患者深受其折磨。“虚瘀”理论是历代医家所探讨的,有关骨痿的一个重要病机,其核心为肾虚为本,血瘀为标。该文由论述“虚瘀”理论引申至骨痿肾虚血瘀病因病机,进而探讨“补肾活血法”相关治则。同时指出耆鹿逐痹胶囊具有益气养阴,补肾健骨,活血祛风之功效,与“补肾活血法”相符,而且其组成药物所含的有效成分对骨质疏松症也有一定程度的防治作用,从而可以得出耆鹿逐痹胶囊可用于防治肾虚血瘀型骨质疏松症,为临床运用其防治骨质疏松症奠定了一定的基础。

基于络病理论探讨冠心汤对气虚血瘀型心绞痛患者心率变异性、心肌微循环及运动耐量的影响

目的:基于络病理论探讨冠心汤对气虚血瘀型心绞痛患者心率变异性、心肌微循环及运动耐量的影响。方法:选取符合纳入标准的112例气虚血瘀型心绞痛患者,依据随机数字表随机分为对照组和治疗组,每组各56例。对照组给予常规西药治疗,治疗组在对照组基础上口服冠心汤治疗,两组均治疗6周。比较两组患者治疗前后心率变异性指标[高频功率(HF)]、正常窦性心搏间期标准差(SDNN)、相邻窦性心搏间期差值>50 ms心搏数百分比(PNN50)、正常相邻窦性心搏间期差值平方根(RMSSD)、运动耐量指标[6分钟步行试验(6MWT)]及中医证候积分的变化情况;比较两组患者治疗后心肌微循环指标,包括左回旋支校正时间流帧计数(LCX CTFC)、右冠脉校正时间流帧计数(RCA CTFC)、左前降支校正时间流帧计数(LAD CTFC)及TIMI心肌组织灌注分级(TMPG)达到3级标准的占比情况;比较两组患者临床疗效与不良反应发生情况。结果:治疗后,两组患者心率变异性指标HF、SDNN、PNN50及RMSSD水平均高于治疗前(P<0.05),且治疗组高于对照组(P<0.001);治疗后,两组患者6MWT水平高于治疗前(P<0.05),中医证候积分水平低于治疗前(P<0.05),且治疗组患者6MWT水平高于对照组(P<0.001),中医证候积分水平低于对照组(P<0.001);治疗后,治疗组LCX CTFC、RCA CTFC、LAD CTFC水平低于对照组(P<0.001),TMPG 3级占比高于对照组(P<0.05);治疗组临床总有效率(94.64%,53/56)高于对照组(80.36%,45/56)(P<0.05);两组不良反应发生率比较,差异无统计学意义(χ^(2)=0.121,P=0.728)。结论:基于络病理论给予气虚血瘀型心绞痛患者冠心汤治疗疗效确切,可更好地缓解患者临床症状,改善患者心率变异性、运动耐量及心肌微循环,且安全性高。

Theory discussion on airway remodeling of bronchial asthma

According to modern research,the pathogenesis of asthma mainly includes airway inflammation,airway hyperresponsiveness,airway remodeling,etc.Airway remodeling is the key factor that leads to the progress of asthma,and it is also the main factor that leads to airway hyperresponsiveness and irreversible airflow restriction.Traditional Chinese medicine believes that"phlegm and blood stasis"block the airway and narrow the lumen is the most important factor in the treatment of asthma.

基于气血理论治疗心力衰竭研究热点及趋势可视化分析

目的分析中医运用气血理论治疗心力衰竭研究现状、热点及趋势,为临床及相关研究提供参考。方法计算机检索中国知识资源总库(CNKI)、中文科技期刊数据库(VIP)、中国学术期刊数据库(万方数据)建库至2022年8月收录的运用气血理论治疗心力衰竭的研究文献。利用CiteSpace5.5.R2软件绘制科学知识图谱,并对发文量、作者、机构、关键词等信息进行分析。结果纳入文献1528篇,年发文量呈波动上升趋势;发文较多的研究机构有辽宁中医药大学附属医院、辽宁中医药大学、北京中医药大学东直门医院、贵州中医药大学第二附属医院、北京中医药大学等;发文较多的作者有张艳、杨冬花、王硕仁、赵明镜、王振涛等;高频关键词有“心力衰竭”“气虚血瘀证”“益气活血法”“心功能”“临床疗效”等,形成13个聚类;突现分析得到17个突现词,2011年之前以纯中医研究为主,2011年之后中西医结合研究热度较高。结论运用气血理论治疗心力衰竭领域不断发展,已形成多个稳定的研究团队,但尚未形成大规模、跨区域的学术合作。目前研究热点集中在中西医结合疗法、药理机制探讨、临床研究等方面。

从阳虚 寒凝 痰浊 血瘀浅析糖尿病下肢血管病变的证治

糖尿病下肢血管病变是糖尿病后期一种严重并发症,是糖尿病致死、致残的主要原因,给患者和社会带来了沉重负担,中医中药早期参与能有效改善该病预后。笔者从“阳虚、寒凝、痰浊、血瘀”等因素影响气血运行的机制着手,尝试探讨糖尿病下肢血管病变的病因病机,并探讨运用“通阳泄浊法”治疗的机制,为该病的诊治提供一种思路和借鉴。

基于“伏邪”理论探讨“热”“瘀”“虚”与小儿难治性肾病的相关性

小儿难治性肾病病因错综复杂,是儿童时期一种棘手的肾脏疾病,其治疗难度大,易反复,预后较差。目前关于中医理论指导的相关研究越来越多,其研究也不断深入,也挖掘出了中医药在临床疾病治疗中的独特优势。伏邪为潜藏在体内而不发作的病邪,伏邪理论在指导小儿难治性肾病的防治过程中发挥出极大优势。笔者以中医“伏邪”理论为线索展开论述,探讨“热”“瘀”“虚”与小儿难治性肾病的关系及相关治疗,为中医药防治该病提供新思路。

基于“气血”理论探讨中医治疗肺系疾病之思路

中医学认为,气血失和,百病丛生,气血是构成人体和维持其生命活动的物质基础。现基于气血理论探讨中医治疗肺系疾病的辨治思路,认为肺系疾病的发病与气血关系密切,系因机体气血功能异常,加之外邪侵袭,导致“肺气虚弱,肺虚络瘀,肺热瘀阻,热壅血瘀”,总结出主要病机是“气血亏虚为本,痰热瘀阻为标”,治疗上应以“调和阴阳、理顺气血”为主要原则,临床上辨证应用“补肺理气、养血活血、化痰逐瘀、清肺热、利肺气、止咳平喘、凉血”之法,为临床从气血角度论治肺系疾病提供新思路。

全息经络头部铜砭刮痧对冠心病气虚血瘀证失眠患者的影响

目的:探讨全息经络头部铜砭刮痧对冠心病气虚血瘀证失眠患者的影响。方法:将120例冠心病气虚血瘀证失眠患者随机分为观察组和对照组,各60例。对照组患者给予心血管系统疾病常规护理措施,观察组患者在其基础上给予全息经络头部铜砭刮痧治疗,1次/d,10~15 min/次,连续治疗30 d后比较两组患者临床疗效、中医证候积分、匹兹堡睡眠质量指数表(PSQI)评分、焦虑自评量表(SAS)评分、生活质量量表(SF-36)评分的差异。结果:治疗后观察组患者临床总有效率、SF-36评分显著高于对照组(P<0.05),中医证候积分、PSQI评分、SAS评分则明显低于对照组(P<0.05)。结论:全息经络头部铜砭刮痧能够有效改善冠心病气虚血瘀证失眠患者临床症状,缓解焦虑情绪,提高睡眠及生活质量。

李晶主任“气虚血瘀夹毒论”治疗慢性萎缩性胃炎经验探析

慢性萎缩性胃炎是由于胃黏膜上皮的反复炎症反应导致胃黏膜病变的一种消化系统慢性疾病,主要症状表现为中上腹隐痛不适、纳差、嗳气、食后腹胀等。世界卫生组织于1978年将其归为胃癌前疾病。山西省中医院李晶主任医师认为,慢性萎缩性胃炎的病机之本是脾气虚,病机之标是胃络瘀阻、兼夹毒邪,在治疗慢性萎缩性胃炎时,一则不忘致病之本——脾胃虚弱,用药轻清平和,时时顾护脾胃;二则重视恢复脾胃升降之职,善用消食导滞之品,助中焦运化;三则谨记瘀血阻络贯穿疾病始终,注重理气活血解毒,同时兼顾养血活血,津血同调。临床治疗以“气虚血瘀夹毒论”为指导,以自拟萎胃方为基础,针对患者不同病情临证灵活加减,配合饮食调整、情志调摄,取得了显著疗效。文章通过案例介绍李晶主任“气虚血瘀夹毒论”治疗慢性萎缩性胃炎的经验,以期为临床提供参考。

中虚精变理论之“中虚致实”观内涵及对男性不育症诊治的启示

中虚精变理论主要阐发精液疾病与脾胃关系,以及精液疾病从脾胃论治的策略。本文在中虚精变理论基础上提出“中虚致实”观,描述脾虚影响水液代谢和阴血运行致实邪蕴积、损伤精室的重要过程,实际上契合了男性不育虚实夹杂的病机特点。“中虚致实”观认为中虚所致之“实”的本体以湿、瘀为核心,可衍生热、痰、浊、毒邪,其内涵可据此转变为“脾虚湿瘀论”,即脾虚和湿、瘀诸邪蕴积共同引发精室损害,导致男性不育的产生。在“脾虚湿瘀论”指导下明确相应的治则规范、方药准备和组方实际,不仅能够启发男性不育临床诊治,所使用的核心方药更有相关报道论证其疗效。但拓展试验研究广度和深度、筛选方药、确立优势病种等仍然是理论转向实践过程中亟待解决的问题。

新型冠状病毒肺炎患者病毒核酸“持久阳性”的中医病机初探

新型冠状病毒肺炎(Corona Virus Disease 2019,COVID-19)患者病毒核酸“持久阳性”是COVID-19治疗中的一大难题,延长了疾病康复周期,阻碍了疫情防控进程,加重了社会负担。由于该病的具体机制目前尚未完全阐明,笔者结合该病的临床表现与众多医家的观点,认为该病的病机特点与中医“湿、瘀、虚”理论相符合,本文试从“湿、瘀、虚”理论来探析COVID-19患者病毒核酸“持久阳性”的病机,旨在为其治疗提供新思路。